Chronic Plaque Psoriasis Completed Phase 3 Trials for Etanercept (DB00005)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0033442 (Chronic Plaque Psoriasis) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01358578 | Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis | Treatment |